Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010055 |
---|---|
Receipt number | R000010954 |
Scientific Title | Phase II study evaluating the efficacy and safety of the Bevacizumab / Docetaxel maintenance therapy beyond stable disease in patients with advanced relapsed non-squamous NSCLC who received Bevacizumab / pemetrexed / platinum induction therapy |
Date of disclosure of the study information | 2013/02/18 |
Last modified on | 2013/02/17 00:00:20 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/02/17 00:03:14 |